Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Longitudinal Monitoring in Surgical Lung Cancer Patients by Circulating Tumor DNA and Its Methylation

NCT03634826 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03634826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03634826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Longitudinal Monitoring in Surgical Lung Cancer Patients by Circulating Tumor DNA and Its Methylation
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 15, 2018
Completion date
January 1, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, lung cancer, lung neoplasm, nsclc